How did In8bio's operating expenses trend in Q4 2024 compared to previous quarters?

IN8bio's operating expenses for Q4 2024 are not currently available. However, the company's financial reports for Q3 and Q2 2024 indicate that the company has not reported any operating expenses for those quarters either. It is important to note that IN8bio has been focusing on securing funding and prioritizing its clinical programs, which may have impacted its operating expenses. The company's successful private placement in October 2024, which raised $12.4 million, is a notable development that could provide the necessary financial support for its operations and clinical development programs through 2026.